Log in
Enquire now
‌

US Patent 11771698 Methods of treating cholangiocarcinoma

Patent 11771698 was granted and assigned to Foundation Medicine on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Foundation Medicine
Foundation Medicine
Date Filed
March 17, 2021
Date of Patent
October 3, 2023
Patent Applicant
Foundation Medicine
Foundation Medicine
Patent Application Number
17204830
Patent Citations
‌
US Patent 7321029 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use
‌
US Patent 7332581 Polypeptide variants with altered effector function
‌
US Patent 7371826 Polypeptide variants with altered effector function
‌
US Patent 7399845 6-modified bicyclic nucleic acid analogs
‌
US Patent 7427672 Artificial nucleic acids of n-o bond crosslinkage type
‌
US Patent 7495088 Modified nucleotide compounds
‌
US Patent 7521541 Cysteine engineered antibodies and conjugates
‌
US Patent 7527791 Humanized anti-TGF-beta antibodies
‌
US Patent 8377921 Compounds and compositions as protein kinase inhibitors
‌
US Patent 9340830 Optimization of multigene analysis of tumor samples
•••
Patent Inventor Names
Vincent A. Miller
Jie He
Siraj Mahamed Ali
Jeffrey S. Ross
Doron Lipson
Philip James Stephens
Matthew J. Hawryluk
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11771698
Patent Primary Examiner
‌
Raymond J. Henley, III
CPC Code
‌
A61K 31/19
‌
A61K 31/498
‌
A61K 31/517

Find more entities like US Patent 11771698 Methods of treating cholangiocarcinoma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.